<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21">
 <label>21</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Maude</surname>
    <given-names>SL</given-names>
   </name>
   <name>
    <surname>Laetsch</surname>
    <given-names>TW</given-names>
   </name>
   <name>
    <surname>Buechner</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Rives</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Boyer</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Bittencourt</surname>
    <given-names>H</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia</article-title>. 
  <source>N Engl J Med</source> (
  <year>2018</year>) 
  <volume>378</volume>(
  <issue>5</issue>):
  <page-range>439–48</page-range>.  
  <pub-id pub-id-type="doi">10.1056/NEJMoa1709866</pub-id>
 </mixed-citation>
</ref>
